Application Nr Approved Date Route Status External Links
ANDA208706 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Duloxetine Delayed-Release Capsules Are Indicated For The Treatment Of: Major Depressive Disorder In Adults Generalized Anxiety Disorder In Adults And Pediatric Patients 7 Years Of Age And Older Diabetic Peripheral Neuropathic Pain In Adults Fibromyalgia In Adults Chronic Musculoskeletal Pain In Adults Duloxetine Delayed-Release Capsules Are A Serotonin And Norepinephrine Reuptake Inhibitor (Snri) Indicated For The Treatment Of The Following Conditions: Major Depressive Disorder (Mdd) In Adults ( 1 ) Generalized Anxiety Disorder (Gad) In Adults And Pediatric Patients 7 Years Of Age And Older ( 1 ) Diabetic Peripheral Neuropathic Pain (Dpnp) In Adults ( 1 ) Fibromyalgia (Fm) ( 1 ) Chronic Musculoskeletal Pain In Adults ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Duloxetine Hydrochloride DULOXETINE HYDROCHLORIDE ZINC1536779

Comments